Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

SEOM clinical guideline on unknown primary cancer (2017).

Losa F, Soler G, Casado A, Estival A, Fernández I, Giménez S, Longo F, Pazo-Cid R, Salgado J, Seguí MÁ.

Clin Transl Oncol. 2018 Jan;20(1):89-96. doi: 10.1007/s12094-017-1807-y. Epub 2017 Dec 11.

2.

Metastases of transverse colon cancer to bilateral ovaries (Krukenberg tumor) and the left breast: A case report.

Luo XY, Wang J, Zhao J, Chen R, Zha XM.

Oncol Lett. 2017 Jul;14(1):31-34. doi: 10.3892/ol.2017.6158. Epub 2017 May 11.

3.

Solitary Gastric Metastasis from a Stage IA Serous Ovarian Carcinoma: A Case Report with Literature Review.

Mizuguchi K, Minato H, Yoshida I, Iwadare J, Kayahashi K, Mitani Y, Watanabe K.

Intern Med. 2017;56(8):915-919. doi: 10.2169/internalmedicine.56.7784. Epub 2017 Apr 15. Review.

5.

Favorable control of advanced colon adenocarcinoma with severe bone marrow metastasis: A case report.

Hanamura F, Shibata Y, Shirakawa T, Kuwayama M, Oda H, Ariyama H, Taguchi K, Esaki T, Baba E.

Mol Clin Oncol. 2016 Nov;5(5):579-582. Epub 2016 Sep 21.

6.

Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports.

Rami S, Han YD, Jang M, Cho MS, Hur H, Min BS, Lee KY, Kim NK.

Ann Coloproctol. 2016 Aug;32(4):150-5. doi: 10.3393/ac.2016.32.4.150. Epub 2016 Aug 31.

7.

The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.

Liu CL, Chen SF, Wu MZ, Jao SW, Lin YS, Yang CY, Lee TY, Wen LW, Lan GL, Nieh S.

Oncotarget. 2016 Mar 22;7(12):14279-90. doi: 10.18632/oncotarget.7306.

8.

Identifying cancer origin using circulating tumor cells.

Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC.

Cancer Biol Ther. 2016 Apr 2;17(4):430-8. doi: 10.1080/15384047.2016.1141839.

9.

Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy.

Wu X, Zhi X, Ji M, Wang Q, Li Y, Xie J, Zhao S.

Am J Cancer Res. 2015 Jan 15;5(2):629-38. eCollection 2015.

10.

Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.

Kim Y, Bae JM, Li G, Cho NY, Kang GH.

PLoS One. 2015 Apr 15;10(4):e0122183. doi: 10.1371/journal.pone.0122183. eCollection 2015.

11.

Development and validation of a microRNA based diagnostic assay for primary tumor site classification of liver core biopsies.

Perell K, Vincent M, Vainer B, Petersen BL, Federspiel B, Møller AK, Madsen M, Hansen NR, Friis-Hansen L, Nielsen FC, Daugaard G.

Mol Oncol. 2015 Jan;9(1):68-77. doi: 10.1016/j.molonc.2014.07.015. Epub 2014 Aug 1.

12.

Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.

Xiao W, Hong H, Awadallah A, Zhou L, Xin W.

PLoS One. 2014 Jan 29;9(1):e86853. doi: 10.1371/journal.pone.0086853. eCollection 2014.

13.

The presentation, pathology, and current management strategies of cutaneous metastasis.

Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC.

N Am J Med Sci. 2013 Sep;5(9):499-504. doi: 10.4103/1947-2714.118918. Review.

14.

Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.

Sopha SC, Gopal P, Merchant NB, Revetta FL, Gold DV, Washington K, Shi C.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2476-86. eCollection 2013.

15.

Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.

Chen SF, Lin YS, Jao SW, Chang YC, Liu CL, Lin YJ, Nieh S.

PLoS One. 2013 May 1;8(5):e54659. doi: 10.1371/journal.pone.0054659. Print 2013.

16.

Challenging diagnosis of a jejunal adenocarcinoma with ovarian metastasis: report of an unusual case.

Huang YY, Pratt JJ, Dabner M, Tjhin W.

BMJ Case Rep. 2013 Apr 10;2013. pii: bcr2013008842. doi: 10.1136/bcr-2013-008842.

17.

Signet ring cell-type adenocarcinoma arising in a mature teratoma of the testis.

Ha HK, Lee W, Lee SD, Lee JZ, Chung MK.

Oncol Lett. 2010 Mar;1(2):299-302. Epub 2010 Mar 1.

18.

Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.

Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT.

Histopathology. 2013 Jan;62(2):267-74. doi: 10.1111/j.1365-2559.2012.04344.x. Epub 2012 Sep 11.

20.

Concomitant pulmonary and thyroid tumors identified by FDG PET/CT and immunohistochemical techniques.

Zhu G, Li H, Zhang Y, Li Y, Liang S, Liu J.

World J Surg Oncol. 2011 Oct 6;9:119. doi: 10.1186/1477-7819-9-119.

Supplemental Content

Support Center